| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT04742075 | Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer | Ovarian Cancer | Active, Not Recruiting | 2026-02-27 |
| Not specified | ||||
| NCT05574673 | Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous… | Ovarian Cancer | Recruiting | 2026-02-27 |
| NCT05142150 | Palliation in Gynae-oncology: Patients Expectations and Assessment of Care (PEACE) | Gynaecological Cancer | Recruiting | 2024-10-01 |
Ovarian Cancer (2)